Document is current
Any future updates will be listed below
-
Authors
Sharma, Gunjan
Tran, Tiffany M.
Bansal, Ishu
Beg, Mohammad Sabique
Bhardwaj, Ruchi
Bassi, Jaspal
Tan, Yuande
Jaiswal, Amit Kumar
Tso, Christine
Jain, Ayushi
Singh, Jay
Chattopadhyay, Parthaprasad
Singh, Archna
Chopra, Anita
Bakhshi, Sameer
Casero, David
Rao, Dinesh S.
Palanichamy, Jayanth Kumar https://orcid.org/0000-0002-3903-7252
-
Funding
Funding for this research was provided by:
NIH Office of the Director (R21CA197441, R01CA264986, T32 CA009056)
The Wellcome Trust DBT India Alliance (Early Career Fellowship: IA/CPHE/15/1/502050)
Department of Biotechnology, Ministry of Science and Technology, India (Senior Research Fellowship, Senior Research Fellowship, Junior Research Fellowship, Junior Research Fellowship)
Science and Engineering Research Board (Overseas Visiting Doctoral Fellowship)
Council of Scientific and Industrial Research (Senior Research Fellowship)
Science and Engineering Research Board (Core Research Grant CRG/2021/004251)
Indian Council of Medical Research (Junior Research Fellowship)
- License Information
-
More Information
Article History
Received: 14 November 2022
Accepted: 27 August 2023
First Online: 5 September 2023
Declarations
:
: Treatment naïve B-ALL patient bone marrow (BM) samples were collected from March 2016 to December 2020 at BR Ambedkar Institute Rotary Cancer Hospital at AIIMS, New Delhi. The study was approved by the Institutional Ethics and Biosafety Committees (IEC-1950/1.04.2016, RP-20/2016). Samples were collected after informed consent from a guardian and assent was taken from children >7 years of age in accordance with the Declaration of Helsinki regulations.
: All authors have read the manuscript and agree to publish the same.
: All authors declare no potential conflict of interest.
